Skip to main content
placeholder image

Ixabepilone and lapatinib for HER2-positive advanced breast cancer: Preclinical rationale and phase I trial

Journal Article


Abstract


UOW Authors


  •   Venter, Deon (external author)

Publication Date


  • 2009

Citation


  • Mainwaring, P. N., Nguyen, T., Price, G., & Venter, D. (2009). Ixabepilone and lapatinib for HER2-positive advanced breast cancer: Preclinical rationale and phase I trial. Journal of Clinical Oncology, 27(15_suppl), 2582. doi:10.1200/jco.2009.27.15_suppl.2582

Web Of Science Accession Number


Start Page


  • 2582

End Page


  • 2582

Volume


  • 27

Issue


  • 15_suppl

Place Of Publication


Abstract


UOW Authors


  •   Venter, Deon (external author)

Publication Date


  • 2009

Citation


  • Mainwaring, P. N., Nguyen, T., Price, G., & Venter, D. (2009). Ixabepilone and lapatinib for HER2-positive advanced breast cancer: Preclinical rationale and phase I trial. Journal of Clinical Oncology, 27(15_suppl), 2582. doi:10.1200/jco.2009.27.15_suppl.2582

Web Of Science Accession Number


Start Page


  • 2582

End Page


  • 2582

Volume


  • 27

Issue


  • 15_suppl

Place Of Publication